GBI (also knowns as Goodwin Biotechnology) is a contract manufacturing organization that specializes in biosimilar and monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates, etc. Its core services cover cell culture, purification, bioconjugation, biosimilars, and cGMP manufacturing areas. In addition, the company delivers a range of support services, including assay development, project management, quality control, translational medicine, and others.